Fentanyl, Screen With Reflexed Confirmation, Urine

CPT: 80307


  • Sublimaze; Abstral; Actiq; Duragesic; Fentora; lonsys; Lazanda; Subsys; Pain Management; Prescription Drug Monitoring; Labcorp MedWatch®; Medical Drug Monitoring

Special Instructions

This assay is intended for pain management. It is not intended for workplace testing and does not comply with state regulatory workplace testing programs.

Expected Turnaround Time

1 - 2 days

Specimen Requirements




20 mL


Urine bottle

Storage Instructions

Maintain specimen at room temperature.

Stability: If arrival at lab will extend beyond 7 days then refrigerate.

Test Details


This test is used to detect and confirm the presence of fentanyl or norfentanyl.


This test was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration.


Initial testing by immunoassay (IA); confirmation of positives by mass spectrometry (MS)

For Providers

Please login to order a test

Order a Test

© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.

CPT Statement/Profile Statement

The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf